Patents by Inventor Paul S. Eder

Paul S. Eder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR IDENTIFYING NOVEL NUCLEIC ACID REGULATORY ELEMENTS AND COMPOUNDS THAT AFFECT THE REGULATION
    Publication number: 20110086105
    Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.
    Type: Application
    Filed: May 17, 2010
    Publication date: April 14, 2011
    Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes
  • Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
    Patent number: 7078171
    Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: July 18, 2006
    Assignee: Message Pharmaceutical, Inc.
    Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes
  • Bacterial RNase P proteins and their use in identifying antibacterial compounds
    Patent number: 6936432
    Abstract: The invention features novel RNase P molecules and nucleic acids encoding the same. Methods for discovery of antimicrobial compounds are also featured.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: August 30, 2005
    Assignee: Message Pharmaceuticals
    Inventors: Venkat Gopalan, Milan Jovanovic, Paul S. Eder, Tony Giordano, Gordon D. Powers, K. Asish Xavier
  • NOVEL BACTERIAL RNASE P PROTEINS AND THEIR USE IN IDENTIFYING ANTIBACTERIAL COMPOUNDS
    Publication number: 20040127480
    Abstract: The invention features novel RNase P molecules and nucleic acids encoding the same. Methods for discovery of antimicrobial compounds are also featured.
    Type: Application
    Filed: March 1, 2001
    Publication date: July 1, 2004
    Inventors: Venkat Gopalan, Milan Jovanovic, Paul S. Eder, Tony Giordano, Gordon D. Powers, K. Asish Xavier
  • Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
    Publication number: 20040091866
    Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.
    Type: Application
    Filed: June 25, 2003
    Publication date: May 13, 2004
    Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes
  • Functional genomic screen for post-transcriptional 5? and 3? regulatory elements
    Patent number: 6448007
    Abstract: The invention features cDNA libraries consisting essentially of cDNA sequences that correspond to different mRNA untranslated region (UTR) sequences separate from adjacent mRNA coding sequences. The invention also features methods for generating these libraries and for identifying a regulatory UTR sequence.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: September 10, 2002
    Assignee: Message Pharmaceuticals
    Inventors: Tony Giordano, Gordon D. Powers, Paul S. Eder, Bonnie-Ann Burnett, Gretchen L. Temeles
  • DNA molecules stabilized by modifications of the 3?-terminal phosphodiester linkage
    Patent number: 6197944
    Abstract: The use of oligodeoxynucleotides modified at the 3′-terminal internucleotide link as therapeutic agents by a method of hybridizing the modified oligonucleotide to a complementary sequence within a targeted mRNA and cleaving the mRNA within the RNA-DNA helix by the enzyme RNaseH to block the expression of the corresponding gene.
    Type: Grant
    Filed: June 29, 1994
    Date of Patent: March 6, 2001
    Assignee: Integrated DNA Technologies, Inc.
    Inventors: Joseph A. Walder, Roxanne Y. Walder, Paul S. Eder, John M. Dagle
  • Methods for decreasing the expression of specifically targeted genes
    Patent number: 5962425
    Abstract: The use of oligodeoxynucleotides modified at the 3'-terminal internucleotide link as therapeutic agents by a method of hybridizing the modified oligonucleotide to a complementary sequence within a targeted mRNA and cleaving the mRNA within the RNA-DNA helix by the enzyme RNaseH to block the expression of the corresponding gene.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: October 5, 1999
    Assignee: University of Iowa Research Foundation
    Inventors: Joseph A. Walder, Roxanne Y. Walder, Paul S. Eder, John M. Dagle
  • Methods for blocking the expression of specifically targeted genes
    Patent number: 5491133
    Abstract: The use of oligodeoxynucleotides modified at the 3'-terminal internucleotide link as therapeutic agents by a method of hybridizing the modified oligonucleotide to a complementary sequence within a targeted mRNA and cleaving the mRNA within the RNA-DNA helix by the enzyme RNaseH to block the expression of the corresponding gene.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: February 13, 1996
    Assignee: University of Iowa Research Foundation
    Inventors: Joseph A. Walder, Roxanne Y. Walder, Paul S. Eder, John M. Dagle